The EML4-ALK fusion gene plays a key oncogenic role in NSCLC, while the genetic or epigenetic inactivation of NKX2-1 may impact the development and abnormal differentiation of NSCLC [37]. Here, NKX2-1 is linked to non-small cell lung carcinoma.